Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006496 · ClinicalTrials.gov registry record

Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)

A clinical trial of Acute Respiratory Distress Syndrome and Lung Diseases, sponsored by Massachusetts General Hospital.

Active
Registry status
4,000
Enrollment target
1
Study location

NCT00006496 is a study of Acute Respiratory Distress Syndrome and Lung Diseases that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 4,000 participants, above the 238-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (1581% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006496, a study of Acute Respiratory Distress Syndrome and Lung Diseases, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2000-02
Est. Completion 2026-12

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00006496

The ClinicalTrials.gov registry entry for NCT00006496 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (1581% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Respiratory Distress Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00006496 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00006496 about?

NCT00006496 is a clinical study titled "Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)". To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).

What is the current status of trial NCT00006496?

This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2000-02. Estimated completion is 2026-12.

What conditions does trial NCT00006496 study?

This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome, Lung Diseases.

Who is sponsoring clinical trial NCT00006496?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006496 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Distress Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.